Pml Tysabri

Featured Health Expert

Tysabri Linked to PML Again

Tysabri has been in the news again this week.  Last Friday the European Medicines Agency (EMEA) announced that they would review the benefits and risks for Tysabri.


The Committee started a review of the benefits and risks of Tysabri, in view of reports of 23 cases of progressive multifocal leukoencephalopathy (PML) worldwide since Tysabri has been on the market. This review is initiated to discuss any additional measures necessary to ensure the safe use of Tysabri and how to balance the...

Read more

More information on "Pml Tysabri"

From Our Experts

See more SharePosts »